SequelSEC

PROCEPT BioRobotics Corp PRCT

Surgical & Medical Instruments & Apparatus · CIK 0001588978 · Fiscal year ends 1231

Revenue
$337.34M
Fiscal year ended 2026-06-30
Operating income
-$114.23M
Fiscal year ended 2026-06-30
Free cash flow
-$84.92M
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$3.20BMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$56.75Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue10.4×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity8.7×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Current ratio6.85x86th
Revenue YoY growth37.2%80th
Long-term debt / equity0.14x21th
SBC / revenue15.5%69th
R&D / revenue23.1%62th
Gross margin63.7%57th
FCF margin-18.9%45th
Net margin-31.0%45th
Operating margin-33.7%45th
CapEx / revenue3.0%50th

PROCEPT BioRobotics Corp (PRCT) reported revenue of $337.34M and net income of -$109.76M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from PROCEPT BioRobotics Corp’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

PROCEPT BioRobotics Corp income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$337.34M
Cost of revenue$120.70M
Gross profit$216.64M
Operating income-$114.23M
Net income-$109.76M
Research & development$78.81M
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$252.06M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

PROCEPT BioRobotics Corp balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$227.91M
Total assets$479.35M
Current assets$420.28M
Total liabilities$139.28M
Current liabilities$64.20M
Total equity incl. NCI$340.07M
Temporary (mezzanine) equityUnavailable
Inventory$77.06M
Accounts receivable$107.61M
GoodwillUnavailable
Long-term debt$51.72M
Accounts payable$15.07M

Cash flow

PROCEPT BioRobotics Corp cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$74.34M
Capital expenditures$10.58M
Investing cash flow-$10.58M
Financing cash flow$10.24M
Net change in cash-$74.80M
Stock-based compensation$52.94M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$7.05M

Derived

PROCEPT BioRobotics Corp derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow-$84.92M
Gross margin64.2%
Operating margin-33.9%
FCF margin-25.2%
SBC / revenue15.7%
Current ratio6.55x
Revenue YoY growth22.7%
Net margin-32.5%
R&D / revenue23.4%
CapEx / revenue3.1%
Long-term debt / equity0.15x
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open PRCT in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-04-30View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-11-05View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-02View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.